BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. Front Med (Lausanne) 2021;8:595371. [PMID: 33718398 DOI: 10.3389/fmed.2021.595371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Lanthier N, Delzenne N. Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time? Cells 2022;11:2718. [DOI: 10.3390/cells11172718] [Reference Citation Analysis]
2 Cheng Z, Wang Y, Li B. Dietary Polyphenols Alleviate Autoimmune Liver Disease by Mediating the Intestinal Microenvironment: Challenges and Hopes. J Agric Food Chem 2022. [PMID: 36005815 DOI: 10.1021/acs.jafc.2c02654] [Reference Citation Analysis]
3 Han AL, Lee HK. Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease. Metabolites 2022;12:664. [DOI: 10.3390/metabo12070664] [Reference Citation Analysis]
4 Riaz F, Wei P, Pan F. Fine-tuning of regulatory T cells is indispensable for the metabolic steatosis-related hepatocellular carcinoma: A review. Front Cell Dev Biol 2022;10:949603. [DOI: 10.3389/fcell.2022.949603] [Reference Citation Analysis]
5 Nascè A, Gariani K, Jornayvaz FR, Szanto I. NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants (Basel) 2022;11:1131. [PMID: 35740032 DOI: 10.3390/antiox11061131] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Saha M, Manna K, Das Saha K. Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model. J Inflamm Res 2022;15:3235-58. [PMID: 35668917 DOI: 10.2147/JIR.S343236] [Reference Citation Analysis]
7 Wang Y, Chen C, Chen J, Sang T, Peng H, Lin X, Zhao Q, Chen S, Eling T, Wang X. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biology 2022;52:102322. [DOI: 10.1016/j.redox.2022.102322] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wen L, Li M, Lin X, Li Y, Song H, Chen H. AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD. Front Bioeng Biotechnol 2022;10:912178. [DOI: 10.3389/fbioe.2022.912178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang L, Dong J, Xu M, Li L, Yang N, Qian G. Association Between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study. Front Med 2022;9:898931. [DOI: 10.3389/fmed.2022.898931] [Reference Citation Analysis]
10 Pedroza-diaz J, Arroyave-ospina JC, Serna Salas S, Moshage H. Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease. Antioxidants 2022;11:975. [DOI: 10.3390/antiox11050975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sadasivam N, Kim Y, Radhakrishnan K, Kim D. Oxidative Stress, Genomic Integrity, and Liver Diseases. Molecules 2022;27:3159. [DOI: 10.3390/molecules27103159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Alzahrani NS, Alshammari GM, El-Ansary A, Yagoub AEA, Amina M, Saleh A, Yahya MA. Anti-Hyperlipidemia, Hypoglycemic, and Hepatoprotective Impacts of Pearl Millet (Pennisetum glaucum L.) Grains and Their Ethanol Extract on Rats Fed a High-Fat Diet. Nutrients 2022;14:1791. [PMID: 35565759 DOI: 10.3390/nu14091791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Salvoza N, Bedin C, Saccani A, Tiribelli C, Rosso N. The Beneficial Effects of Triterpenic Acid and Acteoside in an In Vitro Model of Nonalcoholic Steatohepatitis (NASH). Int J Mol Sci 2022;23:3562. [PMID: 35408923 DOI: 10.3390/ijms23073562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Rebollo-hernanz M, Aguilera Y, Martín-cabrejas MA, Gonzalez de Mejia E. Activating Effects of the Bioactive Compounds From Coffee By-Products on FGF21 Signaling Modulate Hepatic Mitochondrial Bioenergetics and Energy Metabolism in vitro. Front Nutr 2022;9:866233. [DOI: 10.3389/fnut.2022.866233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Androutsakos T, Nasiri-Ansari N, Bakasis AD, Kyrou I, Efstathopoulos E, Randeva HS, Kassi E. SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection. Int J Mol Sci 2022;23:3107. [PMID: 35328527 DOI: 10.3390/ijms23063107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Smirne C, Croce E, Di Benedetto D, Cantaluppi V, Comi C, Sainaghi PP, Minisini R, Grossini E, Pirisi M. Oxidative Stress in Non-Alcoholic Fatty Liver Disease. Livers 2022;2:30-76. [DOI: 10.3390/livers2010003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 de Paula Dias Moreira L, Enes BN, de São José VPB, Toledo RCL, Ladeira LCM, Cardoso RR, da Silva Duarte V, Hermsdorff HHM, de Barros FAR, Martino HSD. Chia (Salvia hispanica L.) Flour and Oil Ameliorate Metabolic Disorders in the Liver of Rats Fed a High-Fat and High Fructose Diet. Foods 2022;11:285. [DOI: 10.3390/foods11030285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Torre P, Motta BM, Sciorio R, Masarone M, Persico M. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Front Med (Lausanne) 2021;8:781567. [PMID: 34957156 DOI: 10.3389/fmed.2021.781567] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Schnegelberger RD, Lang AL, Arteel GE, Beier JI. Environmental toxicant-induced maladaptive mitochondrial changes: A potential unifying mechanism in fatty liver disease? Acta Pharm Sin B 2021;11:3756-67. [PMID: 35024304 DOI: 10.1016/j.apsb.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Mertens J, De Block C, Spinhoven M, Driessen A, Francque SM, Kwanten WJ. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. Front Pharmacol 2021;12:768576. [PMID: 34759828 DOI: 10.3389/fphar.2021.768576] [Reference Citation Analysis]
21 Qu W, Ma T, Cai J, Zhang X, Zhang P, She Z, Wan F, Li H. Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies. Front Med (Lausanne) 2021;8:761538. [PMID: 34746195 DOI: 10.3389/fmed.2021.761538] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Lonardo A. Separating the apples from the oranges: from NAFLD heterogeneity to personalized medicine. Exploration of Medicine. [DOI: 10.37349/emed.2021.00061] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Lonardo A. Separating the apples from the oranges: from NAFLD heterogeneity to personalized medicine. Exploration of Medicine. [DOI: 10.37349/emed.2021.00061] [Reference Citation Analysis]
24 Hu J, Ying H, Yao J, Yang L, Jin W, Ma H, Li L, Zhao Y. Micronized Palmitoylethanolamide Ameliorates Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis via Inhibiting Inflammation and Restoring Autophagy. Front Pharmacol 2021;12:744483. [PMID: 34712137 DOI: 10.3389/fphar.2021.744483] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev 2021;:e3502. [PMID: 34614543 DOI: 10.1002/dmrr.3502] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
26 Chimienti G, Orlando A, Russo F, D'Attoma B, Aragno M, Aimaretti E, Lezza AMS, Pesce V. The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease. Genes (Basel) 2021;12:1439. [PMID: 34573421 DOI: 10.3390/genes12091439] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Eder K, Gessner DK, Ringseis R. Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance. J Anim Sci Biotechnol 2021;12:97. [PMID: 34517929 DOI: 10.1186/s40104-021-00621-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Colucci A, Rocco MC, De Anseris AGE, Nazzaro L, Vajro P, Mandato C. Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path. Exploration of Medicine. [DOI: 10.37349/emed.2021.00051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Ali ES, Rychkov GY, Barritt GJ. TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species. Antioxidants (Basel) 2021;10:1243. [PMID: 34439491 DOI: 10.3390/antiox10081243] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
30 Han JH, Park MH, Myung CS. Garcinia cambogia Ameliorates Non-Alcoholic Fatty Liver Disease by Inhibiting Oxidative Stress-Mediated Steatosis and Apoptosis through NRF2-ARE Activation. Antioxidants (Basel) 2021;10:1226. [PMID: 34439474 DOI: 10.3390/antiox10081226] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
31 Bertran L, Portillo-Carrasquer M, Martínez S, Aguilar C, Lopez-Dupla M, Riesco D, Binetti J, Vives M, Sabench F, Del Castillo D, Richart C, Auguet T. Expression of Jejunal Taste Receptors in Women with Morbid Obesity. Nutrients 2021;13:2437. [PMID: 34371946 DOI: 10.3390/nu13072437] [Reference Citation Analysis]
32 Juanola O, Martínez-López S, Francés R, Gómez-Hurtado I. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. Int J Environ Res Public Health 2021;18:5227. [PMID: 34069012 DOI: 10.3390/ijerph18105227] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
33 Dabravolski SA, Bezsonov EE, Baig MS, Popkova TV, Nedosugova LV, Starodubova AV, Orekhov AN. Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk. Int J Mol Sci 2021;22:4459. [PMID: 33923295 DOI: 10.3390/ijms22094459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]